Royal Bank of Canada’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 6836 |
|
|
2024
Q4 | – | Sell |
-1,490
| Closed | -$5K | – | 6604 |
|
|
2024
Q3 | $5K | Sell |
1,490
-1,375
| -48% | -$4.61K | ﹤0.01% | 6042 |
|
|
2024
Q2 | $9K | Buy |
+2,865
| New | +$9K | ﹤0.01% | 5996 |
|
|
2024
Q1 | – | Sell |
-4,151
| Closed | -$17K | – | 6899 |
|
|
2023
Q4 | $17K | Buy |
4,151
+3,567
| +611% | +$14.6K | ﹤0.01% | 5825 |
|
|
2023
Q3 | $2K | Sell |
584
-508
| -47% | -$1.74K | ﹤0.01% | 6312 |
|
|
2023
Q2 | $3K | Sell |
1,092
-530
| -33% | -$1.46K | ﹤0.01% | 6339 |
|
|
2023
Q1 | $3K | Sell |
1,622
-8,669
| -84% | -$16K | ﹤0.01% | 6312 |
|
|
2022
Q4 | $36K | Buy |
10,291
+3,633
| +55% | +$12.7K | ﹤0.01% | 5595 |
|
|
2022
Q3 | $246K | Buy |
6,658
+174
| +3% | +$6.43K | ﹤0.01% | 4128 |
|
|
2022
Q2 | $123K | Sell |
6,484
-1,372
| -17% | -$26K | ﹤0.01% | 4737 |
|
|
2022
Q1 | $212K | Sell |
7,856
-1,681
| -18% | -$45.4K | ﹤0.01% | 4558 |
|
|
2021
Q4 | $215K | Sell |
9,537
-274
| -3% | -$6.18K | ﹤0.01% | 4753 |
|
|
2021
Q3 | $257K | Buy |
9,811
+284
| +3% | +$7.44K | ﹤0.01% | 4445 |
|
|
2021
Q2 | $305K | Buy |
9,527
+250
| +3% | +$8K | ﹤0.01% | 4249 |
|
|
2021
Q1 | $326K | Buy |
9,277
+8,878
| +2,225% | +$312K | ﹤0.01% | 4078 |
|
|
2020
Q4 | $13K | Sell |
399
-427
| -52% | -$13.9K | ﹤0.01% | 5718 |
|
|
2020
Q3 | $31K | Buy |
826
+800
| +3,077% | +$30K | ﹤0.01% | 5054 |
|
|
2020
Q2 | $1K | Buy |
+26
| New | +$1K | ﹤0.01% | 5994 |
|
|
2020
Q1 | – | Sell |
-36
| Closed | -$1K | – | 6298 |
|
|
2019
Q4 | $1K | Buy |
+36
| New | +$1K | ﹤0.01% | 6072 |
|